Fibrotic Interstitial Lung Disease Early Recognition and Strategic Therapy Study in China
Clinical trial NCT06655090 · RECRUITING
Trial details
- NCT number
- NCT06655090
- Sponsor
- Dai Huaping
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2021-12-01
- Primary completion
- 2024-11-30
- Enrollment
- 10000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.